Abstract:Alzheimer’s disease is a devastating neurodegenerative disorder, the most common among the dementing illnesses. Acetaminophen has gaining importance in neurodegenerative diseases by attenuating the dopaminergic neurodegeneration in Caenorhabditis elegans model, decreasing the chemokines and the cytokines and increasing the anti apoptotic protein such as Bcl-2 in neuronal cell culture. The low concentration acetaminophen improved the facilitation to find the hidden platform in Morris Water Maze Test. Also some … Show more
“…Moreover, the gradual increase in impairment of the two parameters suggested a progressive nature for this impairment, a characteristic feature in AD. The findings here were in line with those of other investigators who showed that icv colchine injection of rats led to impaired memory in a Morris water maze (Kumar & Gupta, 2002;Kumar et al, 2007aKumar et al, , b, 2008Kumar et al, , 2010, a step-through passive avoidance apparatus (Pitchaimani et al, 2012) and a radial arm maze (Ganguly & Guha, 2008).…”
Section: Discussionsupporting
confidence: 81%
“…The type of information gleaned from those types of studies may be useful to compare colchicine-induced neurodegeneration with that associated with other neurodegenerative diseases, such as Alzheimer's Disease (AD). A colchicine (icv)-induced neurodegeneration model has been considered by many as a sporadic model of AD on the basis of impairment of cognitive functions and loss of cholinergic neurons (Ganguly & Guha, 2008;Kumar et al, 2007a;Pitchaimani et al, 2012;Shigematsu & McGeer, 1992).…”
Colchicine induces neurodegeneration, but the extent of neurodegeneration in different areas of the brain in relation to neuroinflammation remains unclear. Such information may be useful to allow for the development of a model to compare colchicine-induced neurodegeneration with other neurodegenerative diseases such as Alzheimer's Disease (AD). The present study was designed to investigate the extent of neurodegeneration along with neuroinflammation in different areas of the brain, e.g. frontal cortex, parietal cortex, occipital cortex, corpus striatum, amygdala and hippocampus, in rats along with memory impairment 21 days after a single intracerebroventricular (icv) injection of colchicine. Memory parameters were measured before and after icv colchicine injection in all test groups of rats (control, sham-operated, colchicineinjected [ICIR] rats). On Day 21 post-injection, rats from all groups were anesthesized and tissues from the various brain areas were collected for assessment of biomarkers of neuroinflammation (i.e. levels of ROS, nitrite and proinflammatory cytokines TNF and IL-1) and neurodegeneration (assessed histologically). The single injection of colchicine resulted in impaired memory and neurodegeneration (significant presence of plaques, Nissl granule chromatolysis) in various brain areas (frontal cortex, amygdala, parietal cortex, corpus striatum), with maximum severity in the hippocampus. While IL-1, TNF, ROS and nitrite levels were altered in different brain areas in the ICIR rats, these parameters had their greatest change in the hippocampus. This study showed that icv injection of colchicine caused strong neurodegeneration and neuroinflammation in the hippocampus of rats and the increases in neurodegeneration were corroborated with those of neuroinflammation at the site. The present study also showed that the extent of neurodegeneration and neuroinflammation in different brain areas of the colchicine-injected rats were AD-like and supported the fact that such rats might have the ability to serve as a sporadic model of AD.
“…Moreover, the gradual increase in impairment of the two parameters suggested a progressive nature for this impairment, a characteristic feature in AD. The findings here were in line with those of other investigators who showed that icv colchine injection of rats led to impaired memory in a Morris water maze (Kumar & Gupta, 2002;Kumar et al, 2007aKumar et al, , b, 2008Kumar et al, , 2010, a step-through passive avoidance apparatus (Pitchaimani et al, 2012) and a radial arm maze (Ganguly & Guha, 2008).…”
Section: Discussionsupporting
confidence: 81%
“…The type of information gleaned from those types of studies may be useful to compare colchicine-induced neurodegeneration with that associated with other neurodegenerative diseases, such as Alzheimer's Disease (AD). A colchicine (icv)-induced neurodegeneration model has been considered by many as a sporadic model of AD on the basis of impairment of cognitive functions and loss of cholinergic neurons (Ganguly & Guha, 2008;Kumar et al, 2007a;Pitchaimani et al, 2012;Shigematsu & McGeer, 1992).…”
Colchicine induces neurodegeneration, but the extent of neurodegeneration in different areas of the brain in relation to neuroinflammation remains unclear. Such information may be useful to allow for the development of a model to compare colchicine-induced neurodegeneration with other neurodegenerative diseases such as Alzheimer's Disease (AD). The present study was designed to investigate the extent of neurodegeneration along with neuroinflammation in different areas of the brain, e.g. frontal cortex, parietal cortex, occipital cortex, corpus striatum, amygdala and hippocampus, in rats along with memory impairment 21 days after a single intracerebroventricular (icv) injection of colchicine. Memory parameters were measured before and after icv colchicine injection in all test groups of rats (control, sham-operated, colchicineinjected [ICIR] rats). On Day 21 post-injection, rats from all groups were anesthesized and tissues from the various brain areas were collected for assessment of biomarkers of neuroinflammation (i.e. levels of ROS, nitrite and proinflammatory cytokines TNF and IL-1) and neurodegeneration (assessed histologically). The single injection of colchicine resulted in impaired memory and neurodegeneration (significant presence of plaques, Nissl granule chromatolysis) in various brain areas (frontal cortex, amygdala, parietal cortex, corpus striatum), with maximum severity in the hippocampus. While IL-1, TNF, ROS and nitrite levels were altered in different brain areas in the ICIR rats, these parameters had their greatest change in the hippocampus. This study showed that icv injection of colchicine caused strong neurodegeneration and neuroinflammation in the hippocampus of rats and the increases in neurodegeneration were corroborated with those of neuroinflammation at the site. The present study also showed that the extent of neurodegeneration and neuroinflammation in different brain areas of the colchicine-injected rats were AD-like and supported the fact that such rats might have the ability to serve as a sporadic model of AD.
“…Thus far, a wide array of neuroprotective effects of APAP has been reported in different studies [24, 27–29, 48]. Previous studies have shown that APAP can protect neurons from degeneration in animal models and cell lines of AD [29] and PD [49] that involves inflammatory and oxidative stress processes. Given the evidence that sepsis can cause cognitive impairment in human subjects [50, 51], our study focused on the effects of APAP in an LPS-induced cognitive impairment mouse model.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, APAP has been shown to protect dopaminergic neurons from oxidative damage evoked by acute exposure to 6-hydroxydopamine or excessive levels of dopamine in vitro [28], suggesting a potential benefit for PD. Finally, recent studies have shown that APAP shows nootropic activity through increasing the escape latency in the step through passive avoidance paradigm task and decreasing acetyl cholinesterase activity in colchicine-induced cognitive impairment (an animal model for AD) in rats [29], suggesting a possible therapeutic effect of APAP in AD.…”
BackgroundConsiderable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice.MethodsA mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP.ResultsMice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice.ConclusionsOur results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway.
“…The colchicine-induced model of neurodegeneration has been used by several authors as a model of SAD [28,29,30], but the exact mechanism of neurodegeneration in this model is not known. If neuroinflammation is related with neurodegeneration in the colchicine-induced AD model, then COX may play an important role in this process.…”
Background: The components of the immune system have been indicated to be linked with the neurotoxicity in Alzheimer's disease (AD). The participation of the immune system in the neurodegeneration in a rat model of colchicine-induced AD has not been explored. Methods: In the present study, hippocampal neurodegeneration along with reactive oxygen species (ROS), nitrite and TNF-α in the hippocampus and some systemic immune responses were measured after 15 and 21 days of intracerebroventricular colchicine injection in rats and again after oral administration of different doses of the anti-inflammatory drug naproxen in AD rats. Results: Chromatolysis and amyloid plaques were found along with higher ROS, nitrite and TNF-α levels in the hippocampus of colchicine-induced AD rats, and these changes were prevented by naproxen in a dose-dependent manner. Alterations in immunological parameters [increased phagocytic activity of white blood cells and splenic polymorphonuclear cells (PMN), increased cytotoxicity and decreased leucocyte adhesive inhibition index (LAI) of splenic mononuclear cells (MNC)] were also observed in colchicine-injected rats, which showed a dose-dependent recovery after oral administration of naproxen in AD rats. The number of plaques, chromatolysis of Nissl granules, TNF-α, nitrite and ROS levels in the hippocampus, phagocytic activity of splenic PMN and LAI of splenic MNC in AD rats showed greater changes in the 21- than in the 15-day study, and the recovery of these parameters after administration of naproxen differed between the two study durations. Conclusion: The present study shows that colchicine-induced neurodegeneration is time dependent and mediated by cyclooxygenase-induced neuroinflammation, which is reflected in the systemic immunological responses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.